53 related articles for article (PubMed ID: 26774590)
21. Varied Clinical Manifestations of LRBA Deficiency (Immune Dysregulation Disorder).
Munirathnam D; Kumar V; Sivasankaran M; Agrawal S
Indian Pediatr; 2021 Mar; 58(3):285-286. PubMed ID: 33713070
[No Abstract] [Full Text] [Related]
22. Study of the polymerisation of cyanic acid, with special reference to dicyanic acid.
WERNER AE; GRAY J
Sci Proc R Dublin Soc; 1947 Jul; 24(18-24):209-14. PubMed ID: 20261792
[No Abstract] [Full Text] [Related]
23. Double-strand break repair through homologous recombination in autosomal-recessive BCL10 deficiency.
García-Gómez S; Chaparro R; Safa A; Van Den Rym A; Martinez-Barricarte R; Lorenzo L; Sánchez-Ramón S; Toledano V; Cubillos-Zapata C; López-Collazo E; Martín-Arranz MD; Martín-Arranz E; Vela M; Gonzalez-Navarro P; Pérez-Martínez A; Casanova JL; Recio MJ; Pérez de Diego R
J Allergy Clin Immunol; 2019 May; 143(5):1931-1934.e1. PubMed ID: 30660642
[No Abstract] [Full Text] [Related]
24. A purely quantitative form of partial recessive IFN-γR2 deficiency caused by mutations of the initiation or second codon.
Oleaga-Quintas C; Deswarte C; Moncada-Vélez M; Metin A; Krishna Rao I; Kanik-Yüksek S; Nieto-Patlán A; Guérin A; Gülhan B; Murthy S; Özkaya-Parlakay A; Abel L; Martínez-Barricarte R; Pérez de Diego R; Boisson-Dupuis S; Kong XF; Casanova JL; Bustamante J
Hum Mol Genet; 2019 Feb; 28(3):524. PubMed ID: 30329057
[No Abstract] [Full Text] [Related]
25. Multimarker risk stratification approach at multiple sclerosis onset.
Fernández-Paredes L; Casrouge A; Decalf J; de Andrés C; Villar LM; Pérez de Diego R; Alonso B; Álvarez Cermeño JC; Arroyo R; Tejera-Alhambra M; Navarro J; Oreja-Guevara C; López Trascasa M; Seyfferth A; García Martínez MA; Álvarez Lafuente R; Albert ML; Sánchez-Ramón S
Clin Immunol; 2017 Aug; 181():43-50. PubMed ID: 28578025
[TBL] [Abstract][Full Text] [Related]
26. Gain-of-function mutation in PIK3R1 in a patient with a narrow clinical phenotype of respiratory infections.
Martínez-Saavedra MT; García-Gomez S; Domínguez Acosta A; Mendoza Quintana JJ; Páez JP; García-Reino EJ; Camps G; Martinez-Barricarte R; Itan Y; Boisson B; Sánchez-Ramón S; Regueiro JR; Casanova JL; Rodríguez-Gallego C; Pérez de Diego R
Clin Immunol; 2016 Dec; 173():117-120. PubMed ID: 27693481
[TBL] [Abstract][Full Text] [Related]
27. Clinical and Immunological Features of Human BCL10 Deficiency.
Garcia-Solis B; Van Den Rym A; Pérez-Caraballo JJ; Al-Ayoubi A; Alazami AM; Lorenzo L; Cubillos-Zapata C; López-Collazo E; Pérez-Martínez A; Allende LM; Markle J; Fernández-Arquero M; Sánchez-Ramón S; Recio MJ; Casanova JL; Mohammed R; Martinez-Barricarte R; Pérez de Diego R
Front Immunol; 2021; 12():786572. PubMed ID: 34868072
[TBL] [Abstract][Full Text] [Related]
28. Differential engulfment of
El Mohtadi M; Pilkington L; Liauw CM; Ashworth JJ; Dempsey-Hibbert N; Belboul A; Whitehead KA
EXCLI J; 2020; 19():1372-1384. PubMed ID: 33192218
[TBL] [Abstract][Full Text] [Related]
29. Actin polymerisation after FCγR stimulation of human fibroblasts is BCL10 independent.
Garcia-Gomez S; Alvarez Doforno R; Martinez-Barricarte R; Torres JM; Ferreira Cerdan A; Davila M; Hernández-Jiménez E; Toledano V; Cubillos-Zapata C; Vallejo-Cremades MT; López-Collazo E; Fernández Arquero M; Sánchez-Ramón S; Casanova JL; Pérez de Diego R
Clin Immunol; 2016 Feb; 163():120-2. PubMed ID: 26774590
[TBL] [Abstract][Full Text] [Related]
30. The CARD11-BCL10-MALT1 (CBM) signalosome complex: Stepping into the limelight of human primary immunodeficiency.
Turvey SE; Durandy A; Fischer A; Fung SY; Geha RS; Gewies A; Giese T; Greil J; Keller B; McKinnon ML; Neven B; Rozmus J; Ruland J; Snow AL; Stepensky P; Warnatz K
J Allergy Clin Immunol; 2014 Aug; 134(2):276-84. PubMed ID: 25087226
[TBL] [Abstract][Full Text] [Related]
31. Bcl10 controls TCR- and FcgammaR-induced actin polymerization.
Rueda D; Gaide O; Ho L; Lewkowicz E; Niedergang F; Hailfinger S; Rebeaud F; Guzzardi M; Conne B; Thelen M; Delon J; Ferch U; Mak TW; Ruland J; Schwaller J; Thome M
J Immunol; 2007 Apr; 178(7):4373-84. PubMed ID: 17371994
[TBL] [Abstract][Full Text] [Related]
32. Immunodeficiency and CARD-BCL10-MALT1.
Pérez de Diego R
Oncotarget; 2015 Aug; 6(24):19934-5. PubMed ID: 26287604
[No Abstract] [Full Text] [Related]
33. The CBM signalosome: potential therapeutic target for aggressive lymphoma?
Yang C; David L; Qiao Q; Damko E; Wu H
Cytokine Growth Factor Rev; 2014 Apr; 25(2):175-83. PubMed ID: 24411492
[TBL] [Abstract][Full Text] [Related]
34. Inherited BCL10 deficiency impairs hematopoietic and nonhematopoietic immunity.
Torres JM; Martinez-Barricarte R; García-Gómez S; Mazariegos MS; Itan Y; Boisson B; Rholvarez R; Jiménez-Reinoso A; del Pino L; Rodríguez-Pena R; Ferreira A; Hernández-Jiménez E; Toledano V; Cubillos-Zapata C; Díaz-Almirón M; López-Collazo E; Unzueta-Roch JL; Sánchez-Ramón S; Regueiro JR; López-Granados E; Casanova JL; Pérez de Diego R
J Clin Invest; 2014 Dec; 124(12):5239-48. PubMed ID: 25365219
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
